Indrayani Biotech Limited (BOM:526445)
India · Delayed Price · Currency is INR 7.80
0.00 (0.00%)
At close: Aug 21, 2026
Indrayani Biotech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 3.7 | -15.57 | 63.65 | 87.37 | 43.93 |
Depreciation & Amortization | 43.01 | 33.68 | 38.05 | 33.47 | 6.59 |
Asset Writedown & Restructuring Costs | - | - | - | 5 | - |
Other Operating Activities | 139.5 | 92.88 | 138.9 | 87.18 | 19.11 |
Change in Accounts Receivable | 1.1 | -191.61 | -95.57 | -158.73 | -93.33 |
Change in Inventory | 35.58 | 10.09 | -301.37 | -106.82 | -4.43 |
Change in Accounts Payable | -95.25 | -138.08 | 146.52 | 169.18 | 24.77 |
Change in Other Net Operating Assets | 188.89 | 141.18 | -293.72 | 45.22 | 44.46 |
Operating Cash Flow | 316.54 | -67.42 | -303.54 | 161.88 | 41.11 |
Operating Cash Flow Growth | - | - | - | 293.76% | 1506.49% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -79.05 | -13.76 | -163.02 | -215.28 | -11.89 |
Sale of Property, Plant & Equipment | - | 74.67 | 0.66 | - | - |
Cash Acquisitions | - | - | - | -195.21 | -0.18 |
Investment in Securities | -0.31 | -0.25 | - | -2.23 | - |
Other Investing Activities | -47.9 | 180.04 | -1.86 | - | - |
Investing Cash Flow | -127.26 | 247.43 | -163.39 | -473.94 | -5.58 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 3.78 | - | 372.26 | 225.85 | 5.5 |
Long-Term Debt Repaid | -75.28 | -64.3 | -8.48 | -4.63 | -13.69 |
Net Debt Issued (Repaid) | -71.5 | -64.3 | 363.78 | 221.22 | -8.19 |
Issuance of Common Stock | 0 | - | 46.33 | 232.82 | - |
Other Financing Activities | -78.11 | -118.66 | 32.28 | -126.64 | -19.11 |
Financing Cash Flow | -149.6 | -182.95 | 442.39 | 327.39 | -27.3 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | -1.43 |
Net Cash Flow | 39.68 | -2.94 | -24.55 | 15.33 | 6.8 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 237.49 | -81.17 | -466.56 | -53.4 | 29.22 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | 16.68% | -6.23% | -28.07% | -3.28% | 4.75% |
Free Cash Flow Per Share | 30.78 | -1.78 | -10.25 | -1.23 | 0.85 |
Levered Free Cash Flow | -147.08 | -524.5 | -478.55 | -301.61 | -31.24 |
Unlevered Free Cash Flow | -87.08 | -457.52 | -416.79 | -270.36 | -19.82 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | - | - | - | 55.57 | 18.8 |
Change in Working Capital | 130.32 | -178.42 | -544.14 | -51.14 | -28.53 |